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Abstract
Background: Between 1990 and 2015, under-5 mortality rate (U5MR) declined by 53%, from an estimated rate of 91 
deaths per 1000 live births to 43, globally. The aim of this study was to determine the share of health research systems 
in this decrease alongside other influential factors. 
Methods: We used random effect regression models including the ‘random intercept’ and ‘random intercept and 
random slope’ models to analyze the panel data from 1990 to 2010. We selected the countries with U5MRs falling 
between the first and third quartiles in 1990. We used both the total articles (TA) and the number of child-specific 
articles (CSA) as a proxy of the health research system. In order to account for the impact of other factors, measles 
vaccination coverage (MVC) (as a proxy of health system performance), gross domestic product (GDP), human 
development index (HDI), and corruption perception index (CPI) (as proxies of development), were embedded in 
the model.
Results: Among all the models, ‘the random intercept and random slope models’ had lower residuals. The same 
variables of CSA, HDI, and time were significant and the coefficient of CSA was estimated at -0.17; meaning, with the 
addition of every 100 CSA, the rate of U5MR decreased by 17 per 1000 live births.
Conclusion: Although the number of CSA has contributed to the reduction of U5MR, the amount of its contribution 
is negligible compared to the countries’ development. We recommend entering different types of researches into the 
model separately in future research and including the variable of ‘exchange between knowledge generator and user.’
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Implications for policy makers
• With the addition of every 100 child-specific articles (CSA) the rate of under-five mortality rate (U5MR) decreased by 17 per 1000 live births.
• Through this study, a new question arises in the context of research policy-making: “What is the appropriate impact level of the health research 
system on health improvement?”
Implications for the public
Research on child mortality can help reduce it by offering useful evidence for utilization in policy-making. 
Key Messages 
Background 
One of the Millennium Development Goals (MDGs) was 
to ‘reduce child mortality’ and one of its targets was to 
“reduce by two-thirds, between 1990 and 2015, the under-
five mortality rate.” Based on the World Health Organization 
(WHO) report, between 1990 and 2015, under-5 mortality 
rate (U5MR) declined by 53% from an estimated rate of 91to 
43 deaths per 1000 live births, globally.1
However, given the importance of health research in the 
promotion of well-being in the world, this question comes to 
mind, “what is the share of countries’ health research systems 
in the reduction of U5MR?” To achieve health, research is 
essential for the advancement of technology, systems, and 
service delivery. In recent years, much emphasis has been laid 
on the role of research in health promotion. Research plays a 
significant role in empowering health systems for improving 
system performance and public health impact.2 The 2013 
WHO report titled “Research for Universal Health Coverage” 
emphasizes the significance of achieving health through 
conducting research. The report states that through the 
utilization of research we must show which service deliveries 
we need; how to increase their coverage; how to improve 
financial risk protection; how to measure the aforementioned; 
and eventually, how to ensure that we have attained universal 
health coverage.3 
Hence, measuring the impact of health research is very 
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important. The impact of health research can be measured 
by two approaches, case studies and ecological studies.4 In 
case studies, a study or a group of studies is selected and their 
effects are examined over time. There are a limited number of 
models and indicators used to examine the effect of research 
through case studies, the most important of which is the 
‘payback model,’ which measures health research impact in 
five domains including ‘knowledge advancement,’ ‘capacity 
building,’ ‘impact on decision-making,’ ‘health impact,’ and 
‘social and economic impact.’5,6 In ecological studies, the 
variables used in the studies are collected and interpreted 
at a global level. For example, the relationship between the 
amount of expenditure on health research and the reduction 
of mortality from certain diseases is evaluated. One of the 
most important challenges in such studies is to find out the 
extent of attribution of health improvement to health research 
(attribution problem) in the presence of other interventions 
that may fall outside the field of health such as interventions 
targeted at education or well-being, or other variables such as 
political will, public opinion and industrial pressure.7 
This study aimed to investigate the impact of the health 
research system on the U5MR trend with respect to other 
interventions and changes through an ecological approach.
Methods
In order to achieve the goals of this study the following steps 
were taken:
1. Development of a Basic Model
Health improvement in countries can be attributed to the 
interventions inside and outside the health system. Health 
system performance and the level of a country’s development 
are critical in its health improvement. In order to reduce 
the ‘attribution problem,’ in addition to the status of health 
research systems in various countries, we considered a model 
in which other variables affecting health status were also 
present:
Health Status ~ Health research system & health system 
performance & development of the country
This model is based on the ‘demand for health capital’ 
(Grossman) model. Here, the presumption is that at individual 
level, health is dependent on inputs (nutrient intake, housing, 
income, recreation, consumption of public goods, education) 
and medical care. At macro level, the determinant factors 
of health are economic, social, and environmental factors.8 
The model applied in this study is an analysis at macro level, 
wherein the level of development of countries is considered 
as a composite proxy of economic, social, and environmental 
factors. The ‘health system performance’ variable is 
considered an important factor in trends of health change, 
which has been implemented separately. Thus, in this study, 
in addition to the variables of the Grossman model, we have 
added the ‘research’ variable to predict the health status. Each 
component of this equation was given a proxy index or an 
appropriate combined indicator. 
2. Determining Appropriate Indices
In this study, the total articles (TA) published in international 
databases and child-specific articles (CSA) were included as 
the performance indicators of the health research system. We 
did not exclude the editorial papers, letters, and commentaries, 
based on previous research, these type of papers contain 
more explicit messages, because they are written by expert 
researchers and offer a body of knowledge.9
Normally, various indicators evaluate health system 
performance. However, since one of the most important 
causes of reduction in the U5MR was the increased measles 
vaccination coverage (MVC), this index was included in 
our model as the proxy of health system performance. As 
mentioned in The MDGs report,10 between 2000 and 2008, 
the first and second doses of measles vaccination accounted 
for a 78% reduction in mortality caused by this disease in the 
world.
In order to account for the development of a country, a variety 
of indicators can be used, each with certain advantages and 
disadvantages. Two main criteria have been introduced for 
this purpose: gross domestic product (GDP) per capita and 
human development index (HDI). As presented in World 
Bank’s website: “GDP per capita is gross domestic product 
divided by midyear population. GDP is the sum of gross value 
added by all resident producers in the economy plus any product 
taxes and minus any subsidies not included in the value of the 
product.”11
According to the United Nations Development Program 
(UNDP), Human Development Reports, the “HDI is a 
summary measure of average achievement in key dimensions 
of human development: a long and healthy life, being 
knowledgeable and having a decent standard of living.” The 
health dimension is measured by life expectancy at birth; the 
education dimension is measured by mean years of schooling 
for adults aged 25 years and expected years of schooling 
for children of school-entering age, and the standard of 
living dimension is measured by gross national income per 
capita.12 We used both GDP and HDI indices in this study. 
Given the importance of corruption perception index (CPI) 
in a country’s administrative performance, this index was 
also included as a proxy of country development; Hunger, 
child mortality, illiteracy, and poverty cannot be eliminated 
inasmuch as corruption usurps the world’s most deprived 
countries’ resources.13
3. Country Selection
Countries were ranked by their U5MR from 1990 in ascending 
order, based on the data provided by the World Bank, and the 
aggregated frequency was calculated. Countries in the first 
to third quartiles were selected. These were selected because 
countries which are in a good health condition (higher than 
the third quartile) have not experienced significant variations 
in the U5MR over time. However, for the countries with poor 
conditions (lower than the first quartile), the reliability of data 
is questionable.
4. Data Collection
We searched PubMed to determine the number of articles 
published by each country. The search strategy was planned 
in a way that it could both specify the total number of health-
related articles published by a country and the articles that 
were written with a particular focus on children. The time 
range was set to 1980 to 2010. To determine the TA published 
by each country, we searched the name of each country 
Yazdizadeh et al
International Journal of Health Policy and Management, 2017, 6(7), 395–402 397
among the titles, MeSH terms, and authors’ affiliations (both 
in lowercase and uppercase letters) in ‘title and author’s 
affiliation.’ Meanwhile, due to the similarity of the names of 
some of the countries with other words the ‘NOT’ command 
was used to avoid those words in the search.
Using the keywords ‘child’ and ‘disease,’ and by adding 
‘malnutrition’ to the list of diseases, ie, HIV/AIDS, diarrhea, 
pneumonia, malaria, measles, and neonatal disorders (with 
the exclusion of injuries/accidents), the number of CSA was 
calculated for each country. The search strategy is shown in 
online Supplementary file 1.
To obtain the required information about the dependent and 
independent variables, well-known databases were used. 
The MVC (% of children aged between 12-23 months which 
have received measles vaccination), GDP per capita (constant 
US$2000), and U5MR from 1990 to 2010 were obtained from 
the World Bank website (http://data.worldbank.org).
The CPI was obtained from the ‘Transparency International’ 
website (http://www.transparency.org/), and HDI was 
extracted from the UNDP website (http://www.undp.org).
Data Analysis
For each country, U5MR data for the five junctures of 1990, 
1995, 2000, 2005, and 2010 were defined as dependent 
variables. For each point, the GDP, the MVC, the mean number 
of articles during a 5-year span before the aforementioned 
years, and the overall CPI mean over a period of 15 years were 
considered as independent variables (because of the missing 
data). The HDI for each year was attributed to the same year’s 
U5MR (for example, the HDI in 1990 was ascribed to the 
U5MR in 1990). MVC data were available only up to 2009. 
As a result, the mean of this index during the period between 
2006 and 2009 was also generalized for 2010. The variables 
calculated for each juncture are shown in Table 1.
At first, we performed univariate analysis between the 
dependent variable (U5MR) and the independent variables. 
The variables that were significant at the P ≤ .2 level were 
included in the model. 
Since the observations for each country are interdependent, 
random effects regression models were used to analyze the 
two models (‘random intercept model’ and ‘random intercept 
and random slope model’). In the random intercept model, the 
intercept can vary between countries. In the random intercept 
and random slope model, however, we extend the flexibility 
of the model to capture different slopes for each country 
for some important variables such as time. To improve the 
efficiency of the models, a centered variable was used for the 
variables of ‘total articles,’ ‘child-specific articles,’ and ‘time’ 
(the year 1990 was considered as the time of origin). 
Since there is a conceptually and statistically significant 
correlation between the variables which represent the 
development of a country, the data were analyzed in the 
following three ways: In accordance with GDP, CPI, and HDI 
(model A), in accordance with GDP and CPI (model B), and 
in accordance with CPI and HDI (model C). These models 
are:
Model A1:
CMRit = αi + β1 × Year + β2 × CSAit + β3 × TAit + β4 × HDIit + β5 × 
CPIit + β6 × GDPcit + β7 × MVCit
Where the country-speciﬁc intercept from the ith country is 
denoted as αis.
Model A2:
CMRit = αi + β1i × Year + β2 × CSAit + β3 × TAit + β4 × HDIit + 
β5 × CPIit + β6 × GDPcit + β7 × MVCit
where the country-speciﬁc intercept and linear time 
slope from the ith country are denoted as αi and β1i.
Model B1:
CMRit = αi + β1 × Year + β2 × CSAit + β3 × TAit + β4 × CPIit + β5 × 
GDPcit + β6 × MVCit
where the country-speciﬁc intercept from the ith country is 
denoted as αis.
Model B2:
CMRit = αi + β1i × Year + β2 × CSAit + β3 × TAit + β4 × CPIit + β5 × 
GDPcit + β6 × MVCit
where the country-speciﬁc intercept and linear time slope 
from the ith country are denoted as αi and β1i.
Model C1:
CMRit = αi + β1 × Year + β2 × CSAit + β3 × TAit + β4 × HDIit + β5 
× CPIit + β6 × MVCit
where the country-speciﬁc intercept from the ithcountry is 
denoted as αis.
Model C2:
CMRit = αi + β1i × Year + β2 × CSAit + β3 × TAit + β4 × HDIit + β5 
× CPIit + β6 × MVCit
where the country-speciﬁc intercept and linear time slope 
from the ith country are denoted as αi and β1i.
This paper is the result of a project sponsored by Tehran 
University of Medical Sciences’ Deputy of Research under 
Project No. 13517-102-01-90. The funding agent does not 
have any role in this project except for financial support.
Results
Descriptive Results
Data from 56 countries were used in this study. The countries 
included in this study were: Azerbaijan, Bangladesh, Benin, 
Bhutan, Bolivia, Burundi, Cambodia, Cameroon, Central 
African Republic, Comoros, Democratic Republic of Congo, 
Republic of Congo, Cote d’Ivoire, Djibouti, Arab Republic 
Table 1. Time-Adjustments of Variables Used in the Model
U5MR TA/CSA/GDP MVC HDI CPI
Time
1990 Average of 1986-1990 Average of 1986-1990 1990
Average of 1996-2010
1995 Average of 1991-1995 Average of 1991-1995 1995
2000 Average of 1996-2000 Average of 1996-2000 2000
2005 Average of 2001-2005 Average of 2001-2005 2005
2010 Average of 2006-2010 Average of 2006-2009 2010
Abbreviations: TA: total articles; HDI: human development index; U5MR, under-five mortality rate; GDP, gross domestic product; MVC, measles vaccination 
coverage; CPI, corruption perception index; CSA, child-specific articles.
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of Egypt, Eritrea, Gabon, Gambia, Ghana, Guatemala, Haiti, 
India, Indonesia, Kenya, Kiribati, Kyrgyz Republic, Lao 
PDR, Lesotho, Madagascar, Maldives, Mauritania, Mongolia, 
Morocco, Myanmar, Namibia, Nepal, Pakistan, Papua New 
Guinea, Peru, Rwanda, Sao Tome and Principe, Senegal, 
Somalia, Sudan, Swaziland, Tajikistan, Tanzania, Timor-Leste, 
Togo, Turkey, Turkmenistan, Uganda, Uzbekistan, Republic 
of Yemen, Zambia, and Zimbabwe.
Figure 1 summarizes the U5MR data for the studied countries 
in the relevant period. Except for Haiti, Rwanda, Lesotho, 
Swaziland, and Zimbabwe, the U5MR reduction trend 
over time appears to be linear for all other countries. Some 
countries such as Maldives, Turkey, Arab Republic of Egypt, 
and Peru have experienced a decrease in the rate of U5MR 
up to 75% compared to their U5MR in 1990. The relative 
reduction in the rate of U5MR in other countries such as the 
Democratic Republic of Congo, Lesotho, and Central African 
Republic, and Cameroon was less than 10% for this period. 
U5MR was constant for some countries such as Somalia. 
Some other countries such as Zimbabwe and Haiti have even 
experienced a 10% increase in their U5MR. 
The main independent variables in this study were the TA and 
number of CSA. Figures 2 and 3 show the changes in these 
variables during the periods under study, respectively. As 
illustrated, except for India and Turkey, these two indicators 
have not changed much over time.
Univariate Analysis
Table 2 shows the univariate analysis between the dependent 
variable (U5MR) and the independent variables. As shown in 
this table, all independent variables in the univariate analysis 
have a significant relationship with U5MR. Table 3 shows that 
these variables significantly correlate with each other. There is 
also a significant correlation between HDI and GDPc for the 
countries under study, and the TA published in a country and 
the number of CSA in the same country. 
Multivariate Analysis
Among all six models, ‘the random intercept and random 
slope models’ has lower residuals and thereby functions better 
than ‘the random intercept models.’ As shown in Tables 4, 
5, and  6, in each of the A, B, and C models, the significant 
variables are identical to each other in ‘the random intercept 
models’ and ‘random intercept and random slope models.’
Model A2, B2, and C2 have similar residuals but in the A2 
 
Figure 1. Country-Specific Trends of U5MR Over a 20-Year Period From 1990 to 2010. Abbreviation: U5MR, under-five mortality rate.
Figure 2. Country-Specific Trends of CSA Over a 20-Year Period 
From 1990 to 2020. Abbreviation: CSA, child-specific articles.
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and C2 models (both of which have HDI as the development 
index), the time coefficients are both similar to each other 
and they are lower than the time coefficient in model B2. This 
shows that models A2 and C2 are more appropriate. In the A2 
and C2 models, the same variables of CSA, HDI, and time are 
significant. In the A2 and C2 models, the coefficient of this 
variable was estimated at -0.17 (P = .05 and .045). 
Among the random intercept models (A1, B1, and C1), A1 
and C1 are similar to each other in terms of residuals and act 
better than B1. 
In the A1 and C1 models, the same variables of HDI and time 
are significant, in C1 the CSA is significant, and in A1 CSA is 
near significant (P = .066).
In general, between the two variables of TA and CSA, CSA is 
significant or near significant in all the models.
Discussion 
The purpose of this study was to evaluate the impact of health 
research on the reduction of U5MR through the ecologic 
approach. The three models used in the ‘random intercept 
and slope models’ created a better fit in terms of residuals. 
In the best models, A2 and C2, the coefficients of CSA were 
significant or near significant (P = .053 in A2 and .045 in 
C2). This means that with the addition of every 100 CSA, the 
rate of U5MR decreased by 17 per 1000 live births. Because 
the coefficient of HDI was higher than the other variables, 
it should be considered when planning for the reduction of 
U5MR. As mentioned in the 2015 MDGs report, more work 
should be done for reducing child mortality and human 
development should be at the center of this focus. However, 
it must be noted that this study is an ecologic one, and 
that there are certain limitations in the interpretation of its 
findings, and that confounding variables must be considered 
in its interpretation. For example, it is not clear how much the 
impact of research has been in that country, and whether or 
not the numbers of articles are associated with a high impact 
rate.
Among the countries examined in this study, no significant 
changes in CSA were observed over time. One reason behind 
the lack of a strong relationship between  CSA and U5MR 
maybe the lack of variance in the CSA.
The association between health research and improvement 
of health status has been investigated in a limited number of 
studies. In one study, the relationship between the number of 
publications in PubMed (as a proxy of stoke knowledge) and 
cancer mortality was examined in the United States. There, 
they observed a strong inverse relationship between the 
number of publications which had received research funding 
and cancer mortality upon considering a 5 and 10 years’ lag. 
The latter finding confirms the 5 years lag time used in our 
study. In other ecological studies, the final goal has been 
the economic payback of research budget.14-19 For example, 
an Australian study showed that returns to investment in 
cardiovascular diseases were nearly 8 times, and in respiratory 
diseases they were 6 times the annual R&D investment.14 
Furthermore, a British study indicated that the best-estimate 
internal rate of return was 10% in cancer-related diseases19 
and 9% in cardiovascular diseases research.17 In order to 
Figure 3. Country-Specific Trends of TA Over a 20-Year Period From 
1990 to 2020. Abbreviation: TA, total articles.
Table 2. The Relationship Between U5MR and the Independent Variables 
(Univariate Analysis)
Covariate Coefficients SE Z P Value
CSA -0.43 0.09 -4.98 < .0001
TA -0.01 0.00 -3.80 < .0001
HDI -408.43 17.14 -23.82 < .0001
GDPc -0.03 0.00 -7.15 < .0001
MVC -1.21 0.09 -13.72 < .0001
CPI -16.96 5.87 -2.89 < .0001
Time   -2.36 0.11 -20.54 < .0001
Abbreviations: CSA, child-specific articles; TA, total articles; HDI, human 
development index; U5MR, under-five mortality rate; GDPc: gross domestic 
production per capita (constant US$2000); MVC, measles vaccination 
coverage; CPI, corruption perception index; SE, standard error.
Table 3. Pearson Correlation Coefficients Between the Independent Variables and U5MR for 56 Countries Between 1990 and 2010
 HDI U5MR CSA  TA GDPc MVC CPI Time
HDI 1.00        
U5MR -0.83 1.00       
CSA 0.06 -0.13 1.00      
TA 0.18 -0.21 0.89 1.00     
GDPc 0.67 -0.49 0.05 0.22 1.00    
MVC 0.51 -0.55 -0.01 0.05 0.21 1.00   
CPI 0.40 -0.36 0.04 0.15 0.47 0.30 1.00  
Time 0.32 -0.44 0.14 0.14 0.08 0.43 0.00 1.00
Abbreviations: CSA, child-specific articles; TA, total articles; HDI, human development index; U5MR, under-five mortality rate; GDPc: gross domestic production 
per capita (constant US$2000); MVC, measles vaccination coverage; CPI, corruption perception index.
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nullify the attribution in these ecological studies, based on 
certain presumptions, the level of attribution was set at 50% 
(analysis was repeated twice with 30% and 70%).17  Anyhow, 
the attribution problem is an important consideration in 
evaluation studies, although some references have suggested 
using contribution instead of attribution, which is a less 
rigorous and quantitative definition.20 In the present study, 
efforts have been made to introduce a linear model to solve the 
attribution problem. Moreover, the variables relevant to health 
improvement outside the health system were considered in 
estimating the impact of research on health improvement. 
In these models, the effect of HDI was approximately 5.78 to 
6.74 times more than the CSA. Now, the question that arises 
is whether this amount is plausible or not?
The point to consider here is that in most of these models, 
CSA is either significant or near significant, while MVC is not 
so. Studies have shown that an MVC <59% is not significantly 
associated with measles-related deaths.21 In the current study, 
the MVC of the years under study was 60%–79% in 30% of the 
countries, and <59% in 66% of the countries, so the result is 
not beyond expectation.
The aforementioned models’ residuals indicate that the 
models for which HDI is the proxy of country development 
function better. This confirms that HDI represents country 
Table 4. Coefficients and Features Of Models A (GDP, CPI, and HDI Variables as the Indicators of Development)
Coefficient SE z P > |z| 95% CI Standard Coefficient
Model A1
CSA -0.17 0.09 -1.84 .066 -0.35 0.01 -4.78
TA 0.00 0.00 1.50 .135 0.00 0.01 3.11
HDI -299.96 27.84 -10.77 .000 -354.52 -245.39 -31.88
CPI -5.22 4.21 -1.24 .215 - 13.46 3.02 -3.83
GDPc 0.00 0.00 0.86 .392 0.00 0.01 2.60
MVC -0.11 0.09 -1.23 .218 -0.29 0.07 -2.09
Time -0.80 0.16 -5.02 .000 -1.12 -0.49 -5.68
Cons 264.69 14.28 18.54 .000 236.70 292.67 98.95
Residual 10.13
Model A2
CSA -0.17 0.09 -1.94 .053 -0.33 0.00 -4.67
TA 0.00 0.00 1.45 .148 0.00 0.01 2.87
HDI -296.15 28.88 -10.25 .000 -352.76 -239.55 -31.48
CPI -6.20 4.23 -1.47 .143 -14.49 2.09 -4.55
GDPc 0.00 0.00 1.37 .171 0.00 0.01 4.25
MVC -0.08 0.08 -0.99 .320 -0.25 0.08 -1.52
Time -0.88 0.21 -4.23 .000 -1.28 -0.47 -6.21
Cons 262.65 14.51 18.10 .000 234.20 291.10 98.99
Residual 7.30
Abbreviations: CSA, child-specific articles; TA, total articles; HDI, human development index; U5MR, under-five mortality rate; GDPc: gross domestic production 
per capita (constant US$2000); MVC, measles vaccination coverage; CPI, corruption perception index; SE, standard error.
 Table 5. Coefficients and Features of Model B (GDP, CPI Variables as the Indicators of Development)
Coefficient SE z P >|z| 95% CI Standard Coefficient
Model B1
CSA -0.21 0.11 -1.87 .061 -0.43 0.01 -5.89
TA 0.01 0.00 1.77 .077 0.00 0.01 4.4
CPI -4.84 5.45 -0.89 .374 -15.52 5.83 -3.55
GDPc -0.02 0.00 -4.64 .000 -0.02 -0.01 -13.97
MVC -0.46 0.10 -4.78 .000 -0.64 -0.27 -8.41
Time -1.59 0.16 -9.64 .000 -1.91 -1.27 -11.25
Cons 171.32 15.20 11.27 .000 141.53 201.12 98.62
Residual 12.08
Model B2
CSA -0.13 0.10 -1.31 .190 -0.32 0.06 -3.66
TA 0.00 0.00 1.47 .142 0.00 0.01 3.25
CPI -6.87 5.60 -1.23 .220 -17.85 4.11 -5.04
GDPc -0.01 0.00 -3.10 .002 -0.02 0.00 -9.89
MVC -0.28 0.08 -3.52 .000 -0.44 -0.12 -5.16
Time -1.86 0.22 -8.55 .000 -2.28 -1.43 -13.16
Cons 163.45 15.40 10.61 .000 133.27 193.64 98.54
Residual 7.84
Abbreviations: CSA, child-specific articles; TA, total articles; HDI, human development index; U5MR, under-five mortality rate; GDPc: gross domestic production 
per capita (constant US$2000); MVC, measles vaccination coverage; CPI, corruption perception index; SE, standard error.
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development in terms of health, better than does GDP. In all 
the models, the time variable was significant. This is because 
variables that are time-dependent and influence U5MR are not 
included in the models. Moreover, when HDI exists in a given 
model, the health system-related indexes (ie, MVC) lose their 
significance. This in turn means that HDI is a valid variable 
in describing the status of development for countries. There 
is no consensus on an index appropriate for measuring the 
development of countries. Starting from 1954 and for many 
consecutive years, GDP was considered as an indicator of social 
welfare. This indicator, however, has always been questioned 
because of two important reasons: It ignores the distribution 
of economic growth in the society and it considers economic 
welfare as the only factor of welfare. As a result, the HDI 
was proposed by the UNDP for this purpose and is annually 
calculated for countries since 1990.22 As evident in this study, 
unlike GDP, if HDI is included in a model, the contribution 
of time is reduced which shows a more proper relationship 
between HDI and country development. These results are 
in favor of the demand for health (Grossman) model, as, by 
accepting the notion that the HDI is an acceptable indicator 
of a country’s economic, social, and environmental status, we 
observe a strong association between this index and health 
(U5MR reduction).
Limitations
The evaluation of research production and health impact 
by ecological methods is very young, thus, knowing the 
limitations will help future studies to picture the reality more. 
There were certain limitations in this study.
We only used the number of articles published by the 
countries as the proxy of health research systems, which is 
not an appropriate index and causes several imitations in the 
interpretation of results in certain ways. Firstly, the number 
of articles does not reflect the quality of research which is an 
important factor for its implementation. Thence, we suggest 
using some indicators as the proxy of quality of research, such 
as citation analysis and journal impact factor23-25 alongside the 
number of papers in future studies. Secondly, research studies 
are implemented only when the necessary policies, programs, 
and resources are available and only when the effects of their 
implementation become apparent.26 Consequently, other 
effects such as the exchange between knowledge generating 
and using organizations and whether the results of research 
studies are made available to the policy-makers at the right 
time, with the right language, and through the right channel 
should also be considered. Thirdly, international studies that 
have played a role in reducing U5MR in specific country, 
but have not been counted in that country’s articles; there is 
no solution for this problem, as it cannot be specified which 
study has affected which country. However, as a confounder, 
the TA around the world can be entered into the model (it 
would be better to enter the articles of those countries that 
have not been included in the study, and better still if the types 
of study could be included as well). 
Fourthly, we did not investigate the impact of different types 
of studies on health research. Obviously, not all types of 
health research have the same bearing on the improvement of 
health. For example, studies which evaluate the effectiveness 
of interventions in special contexts or those that investigate 
the implementation of those interventions are more effective 
in improving health.27 As a result, an increase in the total 
number of studies will not have any considerable impact on the 
improvement of health. Paying attention to the distribution of 
different types of studies is crucial for an accurate evaluation 
of the impact of health research. Perhaps if the impact of 
health system, health services or universal health coverage 
researches in developing countries were reviewed, the impact 
would be different.
Another limitation is using one indicator as the proxy of 
health system performance and health research system. We 
suggest using more than one indicator for them in future 
studies in order to better picture reality. As a proxy of health 
system performance, the studies can use indicators which 
Table 6. Coefficients and Features of Model C (CPI and HDI Variables as the Indicators of Development)
Coefficient SE z P >|z| 95% CI Standard Coefficient
Model C1
CSA -0.18 0.09 -2.02 .043 -0.36 -0.01 -5.16
TA 0.00 0.00 1.76 .078 0.00 0.01 3.49
HDI -278.11 23.36 -11.91 .000 -323.90 -232.33 -29.56
CPI -3.11 4.02 -0.77 .439 -10.99 4.76 -2.28
MVC -0.12 0.09 -1.40 .161 -0.30 0.05 -2.27
Time -0.82 0.16 -5.19 .000 -1.13 -0.51 -5.88
Cons 251.44 12.74 19.74 .000 226.48 276.41 98.14
Residual 10.13
Model C2
CSA -0.17 0.09 -2.01 .045 -0.35 0.00 -4.92
TA 0.00 0.00 1.74 .082 0.00 0.01 3.42
HDI -267.46 24.19 -11.06 .000 -314.87 -220.05 -28.43
CPI -3.71 4.01 -0.93 .355 -11.57 4.15 -2.72
MVC -0.13 0.08 -1.60 .111 -0.29 0.03 -2.37
Time -0.89 0.20 -4.53 .000 -1.28 -0.51 -6.37
Cons 249.31 12.88 19.35 .000 224.07 274.56 98.29
Residual 7.73
Abbreviations: CSA, child-specific articles; TA, total articles; HDI, human development index; U5MR, under-five mortality rate; GDPc: gross domestic production 
per capita (constant US$2000); MVC, measles vaccination coverage; CPI, corruption perception index; SE, standard error.
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have been introduced by the WHO.28
Conclusion
Child-related research has a significant impact on U5MR 
reduction. However, this contribution is negligible compared 
to the effect of development of countries and other time-
related factors. Unlike GDP, if HDI is included in a model, the 
contribution of time reduces which implies the existence of a 
stronger relationship between HDI and health improvement. 
Through this study, a new question arises in the context of 
research policy-making: “What is the appropriate impact level 
of the health research system on health improvement?”
In order to gain deeper understanding of the contribution 
of countries’ health research systems toward the reduction 
of U5MR, conducting studies that investigate the impact of 
different types of research is warranted. Moreover, the effect 
of research will be examined with greater transparency if the 
‘exchange’ variable is also included in the model in future 
studies.
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